Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1982 Sep;46(3):459–516. doi: 10.1038/bjc.1982.227

The British Association for Cancer Research, 23rd annual general meeting. Edinburgh 29--31 March 1982. Abstracts.

PMCID: PMC2011111  PMID: 7126433

Full text

PDF
459

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barranco S. C., Romsdahl M. M., Humphrey R. M. The radiation response of human malignant melanoma cells grown in vitro. Cancer Res. 1971 Jun;31(6):830–833. [PubMed] [Google Scholar]
  2. Bedford P., Fox B. W. The role of formaldehyde in methylene dimethanesulphonate-induced DNA cross-links and its relevance to cytotoxicity. Chem Biol Interact. 1981 Dec;38(1):119–128. doi: 10.1016/0009-2797(81)90158-7. [DOI] [PubMed] [Google Scholar]
  3. Bonfante V., Bonadonna G., Villani F., Di Fronzo G., Martini A., Casazza A. M. Preliminary phase I study of 4'-epi-adriamycin. Cancer Treat Rep. 1979 May;63(5):915–918. [PubMed] [Google Scholar]
  4. Carr B. I., Laishes B. A. Resistance to the cytocidal effects of adriamycin is an early phenotypic change induced during hepatocarcinogenesis. Br J Cancer. 1981 Oct;44(4):567–571. doi: 10.1038/bjc.1981.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Courtenay V. D., Mills J. An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. Br J Cancer. 1978 Feb;37(2):261–268. doi: 10.1038/bjc.1978.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Courtenay V. D., Mills J. An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. Br J Cancer. 1978 Feb;37(2):261–268. doi: 10.1038/bjc.1978.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Courtenay V. D., Mills J. An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. Br J Cancer. 1978 Feb;37(2):261–268. doi: 10.1038/bjc.1978.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cowen D. M., Double J. A., Cowen P. N. Some biological characteristics of transplantable lines of mouse adenocarcinomas of the colon. J Natl Cancer Inst. 1980 Mar;64(3):675–681. [PubMed] [Google Scholar]
  9. Dembo A. J., Van Dyk J., Japp B., Bean H. A., Beale F. A., Pringle J. F., Bush R. S. Whole abdominal irradiation by a moving-strip technique for patients with ovarian cancer. Int J Radiat Oncol Biol Phys. 1979 Nov-Dec;5(11-12):1933–1942. doi: 10.1016/0360-3016(79)90942-8. [DOI] [PubMed] [Google Scholar]
  10. Double J. A., Ball C. R., Cowen P. N. Transplantation of adenocarcinomas of the colon in mice. J Natl Cancer Inst. 1975 Jan;54(1):271–275. doi: 10.1093/jnci/54.1.271. [DOI] [PubMed] [Google Scholar]
  11. Drewinko B., Patchen M., Yang L. Y., Barlogie B. Differential killing efficacy of twenty antitumor drugs on proliferating and nonproliferating human tumor cells. Cancer Res. 1981 Jun;41(6):2328–2333. [PubMed] [Google Scholar]
  12. Feit P. W., Rastrup-Andersen N., Matagne R. Studies on epoxide formation from (2S,3S)-threitol 1,4-bismethanesulfonate. The preparation and biological activity of (2S,3S)-1,2-epoxy-3,4-butanediol 4-methanesulfonate. J Med Chem. 1970 Nov;13(6):1173–1175. doi: 10.1021/jm00300a034. [DOI] [PubMed] [Google Scholar]
  13. Fraser H. Astrocytomas in an inbred mouse strain. J Pathol. 1971 Apr;103(4):266–270. doi: 10.1002/path.1711030410. [DOI] [PubMed] [Google Scholar]
  14. Gescher A., Gibson N. W., Hickman J. A., Langdon S. P., Ross D., Atassi G. N-methylformamide: antitumour activity and metabolism in mice. Br J Cancer. 1982 Jun;45(6):843–850. doi: 10.1038/bjc.1982.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hamburger A. W., Salmon S. E., Kim M. B., Trent J. M., Soehnlen B. J., Alberts D. S., Schmidt H. J. Direct cloning of human ovarian carcinoma cells in agar. Cancer Res. 1978 Oct;38(10):3438–3444. [PubMed] [Google Scholar]
  16. Hamburger A. W., Salmon S. E. Primary bioassay of human tumor stem cells. Science. 1977 Jul 29;197(4302):461–463. doi: 10.1126/science.560061. [DOI] [PubMed] [Google Scholar]
  17. Hamburger A. W., Salmon S. E. Primary bioassay of human tumor stem cells. Science. 1977 Jul 29;197(4302):461–463. doi: 10.1126/science.560061. [DOI] [PubMed] [Google Scholar]
  18. Hancock B. W., Bruce L., May K., Richmond J. Ferritin, a sensitizing substance in the leucocyte migration inhibition test in patients with malignant lymphoma. Br J Haematol. 1979 Oct;43(2):223–233. doi: 10.1111/j.1365-2141.1979.tb03745.x. [DOI] [PubMed] [Google Scholar]
  19. Herberman R. B., Holden H. T. Natural cell-mediated immunity. Adv Cancer Res. 1978;27:305–377. doi: 10.1016/s0065-230x(08)60936-7. [DOI] [PubMed] [Google Scholar]
  20. Hill B. T., Whelan R. D. Assessments of the sensitivities of cultured human neuroblastoma cells to anti-tumour drugs. Pediatr Res. 1981 Aug;15(8):1117–1122. doi: 10.1203/00006450-198108000-00009. [DOI] [PubMed] [Google Scholar]
  21. Ingleton P. M., Coulton L. A., Preston C. J., Martin T. J. Alkaline phosphatase in serum and tumour of rats bearing a hormone-responsive transplantable osteogenic sarcoma. Eur J Cancer. 1979 May;15(5):685–691. doi: 10.1016/0014-2964(79)90142-7. [DOI] [PubMed] [Google Scholar]
  22. Ingleton P. M., Underwood J. C., Hunt N. H., Atkins D., Giles B., Coulton L. A., Martin T. J. Radiation induced osteogenic sarcoma in the rat as a model of hormone-responsive differentiated cancer. Lab Anim Sci. 1977 Oct;27(5 Pt 2):748–756. [PubMed] [Google Scholar]
  23. Iwamoto Y., Hansen I. L., Porter T. H., Folkers K. Inhibition of coenzyme Q10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activity. Biochem Biophys Res Commun. 1974 Jun 4;58(3):633–638. doi: 10.1016/s0006-291x(74)80465-1. [DOI] [PubMed] [Google Scholar]
  24. Kralovic R. C., Zepp F. A., Cenedella R. J. Studies of the mechanism of carcass fat depletion in experimental cancer. Eur J Cancer. 1977 Oct;13(10):1071–1079. doi: 10.1016/0014-2964(77)90003-2. [DOI] [PubMed] [Google Scholar]
  25. Laverick M., Nias A. H. Potentiation of the radiation response of hypoxic mammalian cells by cis-dichlorobis(isopropylamine)trans-dihydroxy platinum IV (CHIP). Br J Radiol. 1981 Jun;54(642):529–530. doi: 10.1259/0007-1285-54-642-529. [DOI] [PubMed] [Google Scholar]
  26. Limas C., Lange P., Fraley E. E., Vessella R. L. A, B, H antigens in transitional cell tumors of the urinary bladder: correlation with the clinical course. Cancer. 1979 Dec;44(6):2099–2107. doi: 10.1002/1097-0142(197912)44:6<2099::aid-cncr2820440621>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  27. MACPHERSON I., MONTAGNIER L. AGAR SUSPENSION CULTURE FOR THE SELECTIVE ASSAY OF CELLS TRANSFORMED BY POLYOMA VIRUS. Virology. 1964 Jun;23:291–294. doi: 10.1016/0042-6822(64)90301-0. [DOI] [PubMed] [Google Scholar]
  28. Namer M., Lalanne C., Baulieu E. E. Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer. Cancer Res. 1980 May;40(5):1750–1752. [PubMed] [Google Scholar]
  29. Newlands E. S., Begent R. H., Kaye S. B., Rustin G. J., Bagshawe K. D. Chemotherapy of advanced malignant teratomas. Br J Cancer. 1980 Sep;42(3):378–391. doi: 10.1038/bjc.1980.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Peter H. H., Dallügge H., Zawatzky R., Euler S., Leibold W., Kirchner H. Human peripheral null lymphocytes. II. Producers of type-1 interferon upon stimulation with tumor cells, Herpes simplex virus and Corynebacterium parvum. Eur J Immunol. 1980 Jul;10(7):547–555. doi: 10.1002/eji.1830100712. [DOI] [PubMed] [Google Scholar]
  31. Reading C. L., Brunson K. W., Torrianni M., Nicolson G. L. Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA tumor virus envelope glycoprotein gp70. Proc Natl Acad Sci U S A. 1980 Oct;77(10):5943–5947. doi: 10.1073/pnas.77.10.5943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Reid M. M., Craft A. W., Todd J. A. Serial studies of numbers of circulating T and B lymphocytes in children with acute lymphoblastic leukaemia. Arch Dis Child. 1977 Mar;52(3):245–247. doi: 10.1136/adc.52.3.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Roscoe J. P., Winslow D. P. Increased ability of ethylnitrosourea-exposed brain cells to survive suspension in agar. Br J Cancer. 1980 Jun;41(6):992–995. doi: 10.1038/bjc.1980.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Rutty C. J., Connors T. A. In vitro studies with hexamethylmelamine. Biochem Pharmacol. 1977 Dec 15;26(24):2385–2391. doi: 10.1016/0006-2952(77)90446-4. [DOI] [PubMed] [Google Scholar]
  35. Rutty C. J., Connors T. A. In vitro studies with hexamethylmelamine. Biochem Pharmacol. 1977 Dec 15;26(24):2385–2391. doi: 10.1016/0006-2952(77)90446-4. [DOI] [PubMed] [Google Scholar]
  36. Rössner S., Boberg J., Carlson L. A., Freyschuss U., Lassers B. W. Comparison between fractional turnover rate of endogenous plasma triglycerides and of intralipid (intravenous fat tolerance test) in man. Eur J Clin Invest. 1974 Apr;4(2):109–114. doi: 10.1111/j.1365-2362.1974.tb00380.x. [DOI] [PubMed] [Google Scholar]
  37. Salmon S. E., Hamburger A. W., Soehnlen B., Durie B. G., Alberts D. S., Moon T. E. Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. N Engl J Med. 1978 Jun 15;298(24):1321–1327. doi: 10.1056/NEJM197806152982401. [DOI] [PubMed] [Google Scholar]
  38. Shaw D., Trotter J. M., Calman K. C. Plasma exchange to control sweats and pruritus in malignant disease. Br Med J. 1980 Nov 29;281(6253):1459–1459. doi: 10.1136/bmj.281.6253.1459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Sheahan D. G., Horowitz S. A., Zamcheck N. Deletion of epithelial ABH isoantigens in primary gastric neoplasms and in metastatic cancer. Am J Dig Dis. 1971 Nov;16(11):961–969. doi: 10.1007/BF02235003. [DOI] [PubMed] [Google Scholar]
  40. Shorthouse A. J., Smyth J. F., Steel G. G., Ellison M., Mills J., Peckham M. J. The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg. 1980 Oct;67(10):715–722. doi: 10.1002/bjs.1800671011. [DOI] [PubMed] [Google Scholar]
  41. Sonakul D., Koompirochana C., Chinda K., Stitnimakarn T. Hepatic carcinoma with opisthorchiasis. Southeast Asian J Trop Med Public Health. 1978 Jun;9(2):215–219. [PubMed] [Google Scholar]
  42. Sparrow A. H., Underbrink A. G., Sparrow R. C. Chromosomes and cellular radiosensitivity. I. The relationship of D0 to chromosome volume and complexity in seventy-nine different organisms. Radiat Res. 1967 Dec;32(4):915–945. [PubMed] [Google Scholar]
  43. Thamavit W., Bhamarapravati N., Sahaphong S., Vajrasthira S., Angsubhakorn S. Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters. Cancer Res. 1978 Dec;38(12):4634–4639. [PubMed] [Google Scholar]
  44. Tomatis L., Cefis F. The effects of multiple and single administration of dimethylnitrosamine to hamsters. Tumori. 1967 Sep-Oct;53(5):447–451. doi: 10.1177/030089166705300502. [DOI] [PubMed] [Google Scholar]
  45. Tritton T. R., Murphree S. A., Sartorelli A. C. Adriamycin: a proposal on the specificity of drug action. Biochem Biophys Res Commun. 1978 Oct 16;84(3):802–808. doi: 10.1016/0006-291x(78)90775-1. [DOI] [PubMed] [Google Scholar]
  46. Underwood J. C., Melick R. A., Loomes R. S., Dangerfield V. M., Crawford A., Coulton L., Ingleton P. M., Martin T. J. Structural and functional correlations in parathyroid hormone responsive transplantable osteogenic sarcomas. Eur J Cancer. 1979 Sep;15(9):1151–1158. doi: 10.1016/0014-2964(79)90131-2. [DOI] [PubMed] [Google Scholar]
  47. Voak D., Sacks S., Alderson T., Takei F., Lennox E., Jarvis J., Milstein C., Darnborough J. Monoclonal anti-A from a hybrid-myeloma: evaluating as a blood grouping reagent. Vox Sang. 1980 Sep;39(3):134–140. doi: 10.1111/j.1423-0410.1980.tb01848.x. [DOI] [PubMed] [Google Scholar]
  48. Voak D., Sacks S., Alderson T., Takei F., Lennox E., Jarvis J., Milstein C., Darnborough J. Monoclonal anti-A from a hybrid-myeloma: evaluating as a blood grouping reagent. Vox Sang. 1980 Sep;39(3):134–140. doi: 10.1111/j.1423-0410.1980.tb01848.x. [DOI] [PubMed] [Google Scholar]
  49. WALDMANN T., TRIER J., FALLON H. Albumin metabolism in patients with lymphoma. J Clin Invest. 1963 Feb;42:171–178. doi: 10.1172/JCI104703. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES